thymidine monophosphate has been researched along with Lymph Node Metastasis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, H; Chen, J; Chen, Q; Guo, Q; Huang, S; Jiang, B; Kang, M; Li, P; Lu, W; Qin, W; Rao, J; Wan, D; Wang, L; Wu, Y; Zheng, W; Zhou, Y | 1 |
1 other study(ies) available for thymidine monophosphate and Lymph Node Metastasis
| Article | Year |
|---|---|
Thymidylate synthase prompts metastatic progression through the dTMP associated EMT process in pancreatic ductal adenocarcinoma.
Topics: Animals; Antimetabolites, Antineoplastic; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Deoxycytidine; Disease Progression; Epithelial-Mesenchymal Transition; Gemcitabine; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Mice, Inbred BALB C; Mice, Nude; Pancreatic Neoplasms; Prognosis; Retrospective Studies; Thymidine Monophosphate; Thymidylate Synthase; Xenograft Model Antitumor Assays | 2018 |